Skip to main content
Keeps Biopharma Inc. logo

Keeps Biopharma Inc. — Investor Relations & Filings

Ticker · 256940 ISIN · KR7256940008 KO Manufacturing
Open in API
Filings indexed 290 across all filing types
Latest filing 2023-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 256940

About Keeps Biopharma Inc.

http://kpscorp.co.kr/

Keeps Biopharma Inc. is a company with operations in both manufacturing and biopharmaceuticals. Its manufacturing activities include the production of equipment for semiconductors and flat panel displays, such as organic light-emitting diodes (OLEDs), as well as cleanroom consumables. Concurrently, the company is expanding its biopharmaceutical business through research and development. Its strategic focus is on building a therapeutic pipeline centered on oncology and metabolic diseases, which includes the development of novel anticancer drugs and combination therapies.

Recent filings

Filing Released Lang Actions
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '(주)케이피에스' covering the period from 2023.01.01 to 2023.06.30. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which fits the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of a major shareholder (Thummim Co., Ltd.) in the company KPS. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-06-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically a sale of 5,000 shares) by an executive (Kim Joo-beom) of the company KPS. This is a standard regulatory filing for insider trading/director dealings in the Korean market.
2023-05-26 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'KPS Corporation' covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Corporate Day). It provides details such as the date, location, purpose, and agenda for the presentation. Since it is an announcement of an event rather than the presentation slides themselves, and it fits the regulatory requirement for disclosing investor meetings, it is classified as a Regulatory Filing (RNS).
2023-05-11 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (KPS) regarding a 'Single Sale/Supply Contract' amendment. It details a change in the delivery date of a contract previously disclosed. Since this is a specific regulatory disclosure regarding a commercial contract and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2023-04-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.